Prescribing practices for Betahistine.
作者信息
Phillips John S, Prinsley Peter R
机构信息
Department of Otolaryngology, James Paget University Hospital, Great Yarmouth, UK.
出版信息
Br J Clin Pharmacol. 2008 Apr;65(4):470-1. doi: 10.1111/j.1365-2125.2007.03079.x. Epub 2008 Feb 12.
Abstract
摘要
相似文献
1
Prescribing practices for Betahistine.倍他司汀的处方规范
Br J Clin Pharmacol. 2008 Apr;65(4):470-1. doi: 10.1111/j.1365-2125.2007.03079.x. Epub 2008 Feb 12.
2
[The effects of betahistine on the function of equilibrium system].[倍他司汀对平衡系统功能的影响]
Otolaryngol Pol. 1997;51 Suppl 25:230-9.
3
[The use of betaserk in patients with cochlear-vestibular disorders].[倍他司汀在耳蜗-前庭疾病患者中的应用]
Vestn Otorinolaringol. 1998(5):49-50.
4
Betahistine: what's new on the agenda?倍他司汀：议程上有什么新内容？
Expert Opin Investig Drugs. 2008 May;17(5):795-804. doi: 10.1517/13543784.17.5.795.
5
Betahistine or Cinnarizine for treatment of Meniere's disease.倍他司汀或桂利嗪治疗梅尼埃病。
Med Arch. 2012;66(6):396-8. doi: 10.5455/medarh.2012.66.396-398.
6
Using betahistine in the treatment of patients with Menière's disease: a meta-analysis with the current randomized-controlled evidence.使用倍他司汀治疗梅尼埃病患者：基于当前随机对照证据的荟萃分析。
Acta Otolaryngol. 2020 Oct;140(10):845-853. doi: 10.1080/00016489.2020.1777326. Epub 2020 Jun 25.
7
8
The benefits of betahistine or vestibular rehabilitation (Tetrax biofeedback) on the quality of life and fall risk in patients with Ménière's disease.倍他司汀或前庭康复（ Tetrax 生物反馈）对梅尼埃病患者生活质量和跌倒风险的影响。
J Laryngol Otol. 2020 Dec;134(12):1073-1076. doi: 10.1017/S0022215120002509. Epub 2020 Dec 7.
9
Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results.关于倍他司汀治疗梅尼埃病的共识会议报告：理论依据、方法及结果
Acta Otorhinolaryngol Ital. 2018 Oct;38(5):460-467. doi: 10.14639/0392-100X-2035.
10
[Delirium in a 73-year-old man after many years of unwise use of betahistine].[一名73岁男性在多年不合理使用倍他司汀后出现谵妄]
Ned Tijdschr Geneeskd. 2004 Nov 20;148(47):2338-41.
引用本文的文献
1
Betahistine for tinnitus.倍他司汀用于治疗耳鸣。
Cochrane Database Syst Rev. 2018 Dec 28;12(12):CD013093. doi: 10.1002/14651858.CD013093.pub2.
2
Hearing function after betahistine therapy in patients with Ménière's disease.倍他司汀治疗梅尼埃病患者后的听力功能
Braz J Otorhinolaryngol. 2016 Sep-Oct;82(5):500-6. doi: 10.1016/j.bjorl.2015.08.021. Epub 2015 Dec 18.
3
4
The evaluation of ozone and betahistine in the treatment of tinnitus.臭氧与倍他司汀治疗耳鸣的疗效评估。
Eur Arch Otorhinolaryngol. 2013 Jul;270(7):1999-2006. doi: 10.1007/s00405-012-2228-8. Epub 2012 Oct 26.
本文引用的文献
1
Meniere's Disease and Migraine.梅尼埃病与偏头痛。
Arch Otolaryngol Head Neck Surg. 2005 May;131(5):460. doi: 10.1001/archotol.131.5.460.
2
Aural vertigo: its diagnosis and treatment; a survey of 268 cases.耳性眩晕：其诊断与治疗；268例病例的调查
J Laryngol Otol. 1957 May;71(5):339-55. doi: 10.1017/s0022215100051860.
3
Ménière's disease.梅尼埃病
Proc R Soc Med. 1954 Aug;47(8):663-70. doi: 10.1177/003591575404700814.
4
Betahistine for Menière's disease or syndrome.倍他司汀用于梅尼埃病或综合征。
Cochrane Database Syst Rev. 2001;2001(1):CD001873. doi: 10.1002/14651858.CD001873.
5
Unusual presentations of acoustic tumours.听神经瘤的不典型表现。
Clin Otolaryngol Allied Sci. 1996 Feb;21(1):80-3. doi: 10.1111/j.1365-2273.1996.tb01030.x.
6
Menière's disease. Etiologic considerations.梅尼埃病。病因学考量。
Arch Otolaryngol Head Neck Surg. 1995 Apr;121(4):377-82. doi: 10.1001/archotol.1995.01890040005001.
7
Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc.听力与平衡委员会梅尼埃病诊断和治疗评估指南。美国耳鼻咽喉-头颈基金会
Otolaryngol Head Neck Surg. 1995 Sep;113(3):181-5. doi: 10.1016/S0194-5998(95)70102-8.
8
Epidemiological and clinical characteristics of Menière's disease in Japan.日本梅尼埃病的流行病学和临床特征。
Acta Otolaryngol Suppl. 1995;519:206-10. doi: 10.3109/00016489509121906.
9
Medical management of vestibular dysfunction.
Otolaryngol Clin North Am. 1984 Nov;17(4):679-84.
10
Hearing loss in the elderly: an epidemiologic study of the Framingham Heart Study Cohort.老年人听力损失：弗明汉心脏研究队列的流行病学研究
Ear Hear. 1985 Jul-Aug;6(4):184-90.
Zotero 插件